Studies
The CTN+ supports clinical trials to find new ways to prevent, treat and manage HIV and other STBBIs, prioritizing a community-based approach of the highest scientific and ethical standards.
-
CTN 272: Canadian HIV and Aging cohort
Determinants of Increased Risk of Cardiovascular Diseases in Individuals Living with HIV
-
CTNPT 011: Monitoring penicillin levels for syphilis
Penicillin therapeutic drug monitoring in the treatment of infectious syphilis. Do low serum penicillin concentrations correlate with treatment failure?
-
CTNPT 014: Kaletra®/Celsentri® combination therapy for HIV in the setting of HCV
An observational study of Kaletra®/Celsentri® combination therapy
-
CTNPT 015: COMO cognition study with HIV+ patients
Pilot project to implement a step-wise investigation that includes Cerebrospinal Fluid analysis as a standard of care for HIV+ individuals with cognitive symptoms
-
CTNPT 021: The (BATARI) Pilot Trial
Bone Antiresorptive Therapy with AntiRetroviral Initiation (BATARI) Pilot Trial
-
-
CTN 265: The sexual confidence study
HIV prevention for gay and bisexual men via reduction of social anxiety and substance use in sexual situations
-
CTN 262: Canadian HIV women’s sexual and reproductive health cohort study (CHIWOS)
Canadian HIV women’s sexual and reproductive health cohort study
-
CTN 260: Raltegravir switch study
A randomized prospective open-label study of switching to raltegravir based antiretroviral therapy (ART) compared to maintaining ritonavir boosted protease inhibitor-based ART on liver fibrosis progression in HIV-HCV co-infected individuals
-
CTN 254: Inflammation as a predictor of HIV disease progression
Predictive value of inflammatory biomarkers in untreated HIV disease progression, and their response to initiation of antiretroviral therapy
Careers
Interested in joining our team? Here are the current career opportunities with the CTN+ and our collaborators. For Fellowship opportunities, please visit our Postdoctoral Fellowship program page.
Learn More